Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.23455 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.18439 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.17558 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.07191 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.11825 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.27998 | 49 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.35383 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.14791 | 49 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.13882 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.1365 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.15624 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.14396 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.17041 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.16324 | 49 |